Evidence map›Paper›PMID 31625841›Full record

ArticleEmerging infectious diseases2019

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-Like Disease, Brazil.

Sandra R Maruyama, Alynne K M de Santana, Nayore T Takamiya, Talita Y Takahashi, Luana A Rogerio, Caio A B Oliveira, Cristiane M Milanezi, Viviane A Trombela, Angela K Cruz, Amélia R Jesus and 5 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Microorganisms · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Assessment of Cross-Reactivity of ChimericDiagnostics (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Co-infection of Leishmania infantum and a Crithidia-related species in a case of refractory relapsed visceral leishmaniasis with non-ulcerated cutaneous manifestation in Brazil.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  10. Natural infection withFrontiers in microbiology · 2023
    Article
  11. First Evidence of Co-Circulation of EmergingTropical medicine and infectious disease · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Catalase impairsVirulence · 2021
    Article
  17. Review
  18. International journal for parasitology. Parasites and wildlife · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sandra R Maruyama
Alynne K M de Santana
Nayore T Takamiya
Talita Y Takahashi
Luana A Rogerio
Caio A B Oliveira
Cristiane M Milanezi
Viviane A Trombela
Angela K Cruz
Amélia R Jesus
Aline S Barreto
Angela M da Silva
Roque P Almeida
José M Ribeiro
João S Silva

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Through whole-genome sequencing analysis, we identified non-Leishmania parasites isolated from a man with a fatal visceral leishmaniasis-like illness in Brazil. The parasites infected mice and reproduced the patient's clinical manifestations. Molecular epidemiologic studies are needed to ascertain whether a new infectious disease is emerging that can be confused with leishmaniasis.

Indexed as

AgedAnimalsBrazilDNA, Ribosomal SpacerEuglenozoa InfectionsGenes, HelminthHumansLeishmaniasis, VisceralMaleMicePhylogenyTrypanosomatinaDNA, Ribosomal SpacerBrazilCrithidia-relatedgenome sequencingparasitessand fliesvector-borne infectionsVisceral leishmaniasis–likewhole-genome sequencing

Identifiers

PMID31625841
PMCPMC6810192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.